As global demand for GLP-1/GIP dual agonists like Tirzepatide (e.g., Mounjaro®) continues to rise, Sunrise Medical provides a full line of injection pen solutions tailored for this breakthrough treatment. Our injection pens are engineered for accurate microdosing, viscous formulation compatibility, and patient-friendly self-injection — making them ideal for both clinical use and mass market rollout.
We offer both reusable and disposable injection pen systems, fully compatible with 1.5ml or 3ml Tirzepatide cartridges, with the following features:
Precise adjustable dosing from 0.01ml to 0.4ml.
Smooth delivery of high-viscosity GLP-1/GIP peptide drugs.
Compatibility with standard Luer lock needle systems.
OEM options for housing design, branding, and packaging.
Built to comply with ISO 11608, CE-mark ready.
Suitable for weight loss and diabetes injectable solutions.
Whether you're developing a clinical trial kit, launching a private-label brand, or expanding your injectable product portfolio, we provide full ODM support from design to scale-up production.
Reach out for free samples, custom specifications, or regulatory support in Europe, Middle East,North American, South Korea, Turkey, and beyond.
